FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1

Overview of attention for article published in Breast Cancer Research, February 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 3 X users

patent: 1 patent

Citations

dimensions_citation: 27 Dimensions

Readers on

mendeley: 36 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,893 followers.

#BestStudyoftheDay: FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1 https://t.co/PrhLfzD3yg - Breast Cancer Res - #breast #cancer #oncology

08 Mar 2021

Reply Repost Favourite

RT @jmedino: FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER,…

15 Feb 2021

Reply Repost Favourite

FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1 https://t.co/udCEVgTBuO #hfuenla @HUFuenlabrada #Oncología Breast Cancer Res. 2021 Feb 12;23(1):21. doi: 10.118

15 Feb 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.